{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:16Z","timestamp":1755216736795,"version":"3.43.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:p>Inflammatory myofibroblastic tumors (IMTs) are rare in neonates. IMTs of the tongue are also very rare in infancy, with only 1 case reported in this age group. The mainstay of therapy has traditionally been surgery, which can be devastating to surrounding structures and negatively impact prognosis. Approximately 50% of IMTs harbor a translocation involving the anaplastic lymphoma kinase gene. We describe a case of IMT of the tongue in a neonate treated with debulking and an anaplastic lymphoma kinase inhibitor. The patient achieved complete response and remains disease-free 1.5 year following completion of therapy.<\/jats:p>","DOI":"10.1097\/mph.0000000000001907","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T04:44:05Z","timestamp":1596861845000},"page":"e521-e524","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Anaplastic Lymphoma Kinase Inhibitor in Treatment of Inflammatory Myofibroblastic Tumor of the Tongue in Infancy"],"prefix":"10.1097","volume":"43","author":[{"given":"Karishma","family":"Rao","sequence":"first","affiliation":[{"name":"Division of Neonatal-Perinatal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Farooki","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology Oncology\/BMT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Guest","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology Oncology\/BMT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Chastain","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology Oncology\/BMT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Gener","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Children\u2019s Mercy Hospital, Kansas City, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangaram","family":"Akangire","sequence":"additional","affiliation":[{"name":"Division of Neonatal-Perinatal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1200\/JCO.2017.73.4830","article-title":"Targeting ALK with crizotinib in pediatric anaplastic large cell lymphoma and inflammatory myofibroblastic tumor: a Children\u2019s Oncology Group Study","volume":"35","author":"Moss\u00e9","year":"2017","journal-title":"J Clin Oncol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cancergen.2013.10.002","article-title":"A novel ALK rearrangement in an inflammatory myofibroblastic tumor in a neonate","volume":"206","author":"Owusu-Brackett","year":"2013","journal-title":"Cancer Genet"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0218492317739474","article-title":"Inflammatory myofibroblastic tumor of heart in a 4-month-old infant","volume":"26","author":"Syed","year":"2018","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1017\/S1047951109990746","article-title":"Echogenic mass in the right atrium after surgical ventricular septal defect closure: thrombus or tumour?","volume":"20","author":"De Winkel","year":"2010","journal-title":"Cardiol Young"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13256-016-0967-7","article-title":"Laryngeal inflammatory myofibroblastic tumor (IMT): a case report and review of the literature","volume":"10","author":"Tay","year":"2016","journal-title":"J Med Case Rep"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1067\/mhn.2003.45","article-title":"Inflammatory myofibroblastic tumor in the neonate: a case report","volume":"128","author":"Klein","year":"2003","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jpedsurg.2015.11.015","article-title":"Inflammatory myofibroblastic tumors in children","volume":"51","author":"Dalton","year":"2016","journal-title":"J Pediatr Surg"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1368-8375(99)00091-3","article-title":"Sclerosing inflammatory myofibroblastic tumour of the tongue: an immunohistochemical and ultrastructural study","volume":"36","author":"Ide","year":"2000","journal-title":"Oral Oncol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1034\/j.1601-0825.2001.00696.x","article-title":"How to manage oral inflammatory myofibroblastic tumor (inflammatory pseudotumor)?","volume":"7","author":"Pankaj","year":"2001","journal-title":"Oral Dis"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bjoms.2006.01.005","article-title":"Inflammatory myofibroblastic tumour of the tongue: a case report","volume":"45","author":"Gleizal","year":"2007","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D31Q0631BM","article-title":"Inflammatory myofibroblastic tumor of the tongue: report of an unusual case in a teenage patient","volume":"18","author":"Louren\u00e7o","year":"2012","journal-title":"Dermatol Online J"},{"key":"R12-20250804","first-page":"787824","article-title":"Inflammatory myofibroblastic tumor: a rare tumor in the tongue","author":"YucelEkici","year":"2013","journal-title":"Case Rep Otolaryngol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15513815.2017.1385667","article-title":"Inflammatory myofibroblastic tumor of the tongue. Report of a pediatric case and review of the literature","volume":"37","author":"Caporalini","year":"2018","journal-title":"Fetal Pediatr Pathol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00405-012-2026-3","article-title":"Inflammatory myofibroblastic tumors of the head and neck: evaluation of clinicopathologic and prognostic features","volume":"269","author":"Devaney","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","article-title":"Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions","volume":"4","author":"Lovly","year":"2014","journal-title":"Cancer Discov"},{"issue":"suppl 3","key":"R17-20250804","doi-asserted-by":"crossref","first-page":"iii4","DOI":"10.1093\/annonc\/mdw301","article-title":"The role of the ALK receptor in cancer biology","volume":"27","author":"Hallberg","year":"2016","journal-title":"Ann Oncol"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/modpathol.3880352","article-title":"ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor","volume":"14","author":"Coffin","year":"2001","journal-title":"Mod Pathol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","article-title":"First-line crizotinib versus chemotherapy in ALK-positive lung cancer","volume":"371","author":"Solomon","year":"2014","journal-title":"N Engl J Med"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(13)70095-0","article-title":"Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children\u2019s Oncology Group phase 1 consortium study","volume":"14","author":"Moss\u00e9","year":"2013","journal-title":"Lancet Oncol"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaapos.2016.01.009","article-title":"Management of anaplastic lymphoma kinase positive orbito-conjunctival inflammatory myofibroblastic tumor with crizotinib","volume":"20","author":"Kiratli","year":"2016","journal-title":"J AAPOS"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/MPH.0000000000000498","article-title":"Complete and repeated response of a metastatic ALK-rearranged inflammatory myofibroblastic tumor to crizotinib in a teenage girl","volume":"38","author":"Gaudichon","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"R23-20250804","first-page":"65","article-title":"Crizotinib in ALK+ inflammatory myofibroblastic tumors\u2014current experience and future perspectives","author":"Theilen","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/1078155219879757","article-title":"How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature","volume":"26","author":"Alan","year":"2020","journal-title":"J Oncol Pharm Pract"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:12:39Z","timestamp":1754338359000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001907","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"assertion":[{"value":"2020-03-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}